Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report

<p>Abstract</p> <p>Background</p> <p>Postprandial hyperlipidemia impairs endothelial function and participates in the development of atherosclerosis. We investigated the postprandial effects of a dipeptidyl peptidase IV inhibitor, alogliptin, on endothelial dysfunction...

Full description

Bibliographic Details
Main Authors: Noda Yoko, Miyoshi Toru, Oe Hiroki, Ohno Yuko, Nakamura Kazufumi, Toh Norihisa, Kohno Kunihisa, Morita Hiroshi, Kusano Kengo, Ito Hiroshi
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Cardiovascular Diabetology
Subjects:
Dipeptidyl peptidase IV inhibitor
Postprandial lipid
Triglyceride-rich lipoprotein
Endothelial dysfunction
Alogliptin
Online Access:http://www.cardiab.com/content/12/1/8

Internet

http://www.cardiab.com/content/12/1/8

Similar Items